CardioRenal, a pioneer in the remote treatment of patients with severe chronic kidney disease (CKD), has announced that its TENOR device has obtained Breakthrough Device Designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA ..read more

Cellular Origins has launched Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy (ISCT) Annual Meeting 2023. Designed to automate the manufacturing of advanced therapies without significant process redevelopment, Constellation combines aseptic fluid handling technologies with advanced automation ..read more

Avacta, a life sciences company developing targeted oncology drugs and diagnostics, has acquired Belgian firm Coris Bioconcept which develops, manufactures and markets rapid diagnostic test kits ..read more

New research has revealed further details of how Alzheimer’s disease is caused, and a blood test could predict who will go on to develop the condition. A new paper published in Nature Medicine by staff at the University of Pittsburgh School of Medicine found that the build-up of amyloid protein in the brain, long associated with the disease, may in itself not be enough to cause symptoms ..read more

New regulatory recognition routes for medicines will be established using approvals from Australia, Canada, the European Union, Japan, Switzerland, Singapore and the United States, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced ..read more

PathPresenter, the global image sharing platform for pathology, has announced that its free public platform now has more than 50,000 registered users in 172 countries. Nearly 7,000 users have joined the pathology image sharing community in the past 12 months ..read more

The Institute of Biomedical Science (IBMS) has published its 2022 Annual Report, reflecting on the support it is providing its members and how it is using its channels to raise awareness of biomedical science ..read more

Validair Monitoring Solutions Ltd has chosen to rebrand its business and has changed its name to FMS. The move comes as the company expands into new sectors with facility-wide and cleanroom airborne particle monitoring increasingly relevant in markets beyond the pharmaceutical industry ..read more

A brand-new genetic research resource, known as a ‘biobank’, will be piloted by the Medicines and Healthcare products Regulatory Agency (MHRA) in a joint venture with Genomics England to better understand how a patient’s genetic makeup can impact the safety of their medicines ..read more

The Institute of Biomedical Science (IBMS) has collaborated with The Royal College of Pathologists (RCPath) and The Association for Clinical Biochemistry and Laboratory Medicine (ACB) to produce a strategy document aimed at those responsible for planning and commissioning novel patient services outside of traditional care settings ..read more